MRI-guided rTMS for depression in adolescents
About this title
Read the official source — NCT07185438This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
Understand this study
What is this study about?
This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
Who could participate?
This study is for people with depression. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.
- Listed locations
- ChongqingSee all locations and recruitment
What to know before participating
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 45
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Sponsor type
- University
- Study type
- Device
- Intervention type
- Device
- Locations
- China
- Age range
- From 12 Years to 18 Years
- Official registry ID
- NCT07185438
- Official title
Show the full official title
Feasibility, Safety, and Preliminary Clinical Efficacy of Magnetic Resonance Imaging-guided Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression: A Randomized, Double-Blind, Controlled Pilot Study
Recruitment & locations
Chongqing
Interested in joining this study?
Questions about this study
What is this study about?
This study evaluates the safety and effectiveness of transcranial magnetic stimulation for people with depression.
What will I need to do?
You will have MRI scans.
Who is behind this study?
The study sponsor is First Affiliated Hospital of Chongqing Medical University, a university.
Who can participate?
This study is for people with depression. Listed age limits: 12 years to 18 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as recruiting.
